Literature DB >> 6461057

Subpopulations of T-lymphocytes in multiple myeloma.

A Pezzutto, G Semenzato, C Agostini, R Raimondi, G Gasparotto.   

Abstract

The percentage and absolute numbers of T lymphocytes bearing Fc receptor for IgG and IgM were evaluated in 13 patients with multiple myeloma and in a group of controls of the same age range. An increase in the percentage of the TG cells was found, whereas TM cell numbers were not different from those of the controls. In order to better define the properties of the TG lymphocytes, their ability to suppress the PWM-induced B cell differentiation was tested in an in vitro experimental assay. TG cells from multiple myeloma exert a suppressor activity as the TG of the controls in this system. The possible interpretation of suppressor T cell increases in these patients is discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6461057     DOI: 10.1111/j.1600-0609.1981.tb01670.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  6 in total

Review 1.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

2.  Patterns of T cell subset alterations in myelo- and lymphoproliferative disorders.

Authors:  G Fiorini; A Geniram; G Frezzini; S Eridani
Journal:  Blut       Date:  1984-05

3.  Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseases.

Authors:  G De Rossi; G De Sanctis; V Bottari; M Tribalto; M Lopez; M T Petrucci; L Fontana
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Production of interleukin 2 in multiple myeloma.

Authors:  T Commes; B Klein; M Jourdan; R Bataille
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

5.  Imbalances of T-cell subsets in monoclonal gammopathies.

Authors:  L Bergmann; P S Mitrou; K C Weber; W Kelker
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.

Authors:  H M Serra; M J Mant; B A Ruether; J A Ledbetter; L M Pilarski
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.